AMWL vs LLY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial profile with a Piotroski F-Score of just 1/9, indicating severe operational and financial distress. Despite a low Price/Book and Price/Sales ratio suggesting potential value, persistent unprofitability, negative earnings momentum, and deteriorating revenue growth paint a bleak picture. Insider selling activity and a lack of analyst consensus further undermine confidence, while the company's long-term price performance has been catastrophic, down 99.3% over five years. Although the balance sheet shows low leverage and strong liquidity, these are overshadowed by systemic profitability and growth failures.
LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
AMWL vs LLY: Head-to-Head Comparison
This page compares American Well Corporation (AMWL) and Eli Lilly and Company (LLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.